Related Experiment Video

Updated: Sep 8, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

972

Astrocytes provide a unique biomarker for Alzheimer's and other pathologies

Eric Siemers1

  • 1Acumen Pharmaticals, United States.

The Journal of Prevention of Alzheimer'S Disease
|June 21, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

3.3K
Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.5K

Related Experiment Videos

Last Updated: Sep 8, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

972
Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

3.3K
Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.5K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

Articles linked to this work by shared authors, journal, and citation graph.

Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study.

Trials·2026

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Recruitment and eligibility in a Phase 1 early Alzheimer's disease trial of Sabirnetug.

Alzheimer's & dementia (New York, N. Y.)·2025

Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2025

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2025

National prevalence and care needs of dementia in adults aged ≥55 years: Findings from the china mental health survey summary box.

The journal of prevention of Alzheimer's disease·2026

Oxidation over omega-3: Reinterpreting the paradoxical link between fish oil supplements and accelerated cognitive decline.

The journal of prevention of Alzheimer's disease·2026

Do methodological limitations and confounding factors explain the apparent acceleration of cognitive decline in older adults taking omega-3 fatty acid supplements?

The journal of prevention of Alzheimer's disease·2026

Prevalence of dementia and BPSD in community-dwelling older adults with advanced care needs: a nationwide survey in Taiwan.

The journal of prevention of Alzheimer's disease·2026

Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.

The journal of prevention of Alzheimer's disease·2026

Brain health strategies in middle-aged individuals with mild neurocognitive disorder: a scoping review.

The journal of prevention of Alzheimer's disease·2026

Cell Type-Specific Extracellular Vesicles in Mouse Brain: Proteomic Signatures Highlight Astrocytic GlialCAM Network and GPCR Enrichment.

Glia·2026

Circulating neuron-derived cfDNA for blood-based detection of Alzheimer's and other neurodegenerative conditions.

Frontiers in neurology·2026

Molecular signaling pathways shaping astrocyte-microglia crosstalk in health and disease.

Frontiers in molecular neuroscience·2026

Neurocognitive Recovery After Liver Transplantation Is Driven by Metabolite-mediated Reactivation of Cortical Networks.

Transplantation·2026

Development and validation of a long-term co-maturation protocol for human stem cell-derived microglia and neuronal networks.

Stem cell reports·2026

Beyond inflammation: Cannabinoid receptors as metabolic checkpoints in glial reprogramming during neurodegeneration.

International immunopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us